• Opinion
• [Reporter's view] Legalization of Non-face-to-face Care
• by Lee, Jeong-Hwan Aug 18, 2022 05:48am

• Policy
• KDCA opposes use of Paxlovid in healthy 50s
• by Lee, Jeong-Hwan Aug 18, 2022 05:48am

• Policy
• Why is price different btw patent-expired original/generic
• by Lee, Tak-Sun Aug 18, 2022 05:47am

• Product
• Settlement of Xarelto price difference
• by Jung, Heung-Jun Aug 18, 2022 05:47am

• Opinion
• [Reporter’s View] Industry sullen over revised PE exemption
• by Eo, Yun-Ho Aug 17, 2022 05:52am

• Policy
• KDCA will announce its plan to inoculate bivalent vaccine
• by Lee, Jeong-Hwan Aug 17, 2022 05:52am

• Company
• Sanofi to supply flu vaccine Vaxigrip Tetra Nationwide
• by Aug 17, 2022 05:52am

• Policy
• Novavax vaccine approved for use for 12+ years in Korea
• by Lee, Hye-Kyung Aug 17, 2022 05:52am

• Policy
• Generic exclusivity of Ticagrelor terminated but no benefits
• by Lee, Tak-Sun Aug 16, 2022 05:47am

• Opinion
• [Reporter’s View] MFDS opens up, discloses contact info
• by Lee, Hye-Kyung Aug 16, 2022 05:46am